“Seven years after their publication, the Medical Devices and In Vitro Diagnostic Medical Devices Regulations continue to hamper access to lifesaving and life-sustaining medical technologies as they are plagued by inefficient and unpredictable processes, skyrocketing cost of compliance, insufficient support for innovation and a lack of accountable governance.”
Strong words from industry association MedTech Europe in a statement responding to news that Ursula von der Leyen has been...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?